Funders · Entity Annotation Prototype (beta)

Evaluation of the performance and safety of adding the iron chelator MEX-CD1 to dialysate during continuous veno-venous haemodialysis for removing excess labile iron in intensive care patients with sepsis-associated acute kidney injury - the Iron in Intensive Care trial (IRON-I.C.): protocol for a phase I–II randomised crossover pilot study

bmjopen · abstract · 2025-12-23 · 1 matching annotations

78.8%

Comité de Protection des Personnes French National Agency for Safety of Drugs and Medical Devices NCT07236463 sepsis-associated acute kidney injury MEX-CD1 Nîmes University Hospital Metal EXtraction - Chitosan DOTAGA 1 renal replacement therapy

…s and dissemination Ethical approval has been obtained from the Comité de Protection des Personnes (no. 25.01220.000448) and the French National Agency for Safety…

Browse funders

French National Agency for Safety of Drugs and Medical Devices

Articles mentioning French National Agency for Safety of Drugs and Medical Devices